Tested Applications
| Positive WB detected in | mouse skeletal muscle tissue |
| Positive IHC detected in | human skeletal muscle tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
24610-1-AP targets MBNL3 in WB, IHC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag20113 Product name: Recombinant human MBNL3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 156-230 aa of BC042090 Sequence: SAASAMALQPGTLQLIPKRSALEKPNGATPVFNPTVFHCQQALTNLQLPQPAFIPAGPILCMAPASNIVPMMHGA Predict reactive species |
| Full Name | muscleblind-like 3 (Drosophila) |
| Calculated Molecular Weight | 354 aa, 39 kDa |
| Observed Molecular Weight | 38 kDa |
| GenBank Accession Number | BC042090 |
| Gene Symbol | MBNL3 |
| Gene ID (NCBI) | 55796 |
| RRID | AB_2879637 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NUK0 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
MBNL3, also named as Muscleblind-like protein 3 or Cys3His CCG1-required protein, is a 354 amino acid protein, which contains four C3H1-type zinc fingers and belongs to the muscleblind family. MBNL3 localizes in the nucleus and is highly expressed in the placenta. MBNL3 mediates pre-mRNA alternative splicing regulation and plays a role in myotonic dystrophy pathophysiology. MBNL3 could inhibit terminal muscle differentiation, acting at approximately the time of myogenin induction.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for MBNL3 antibody 24610-1-AP | Download protocol |
| WB protocol for MBNL3 antibody 24610-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The MBNL3 polyclonal antibody (Cat# 24610-1-AP) has a total of 2 citations published in Scientific Reports and Cell Cycle. The cited studies address tumor progression and metastasis in cholangiocarcinoma, where MBNL3 serves as a prognostic biomarker, and RNA regulation mechanisms involving TRIM71 binding to IMP1 for positive and negative regulation of target RNAs. Both citations involve human samples, with applications including IHC and Western blot.
| Species | Application | Title |
|---|---|---|
Sci Rep MBNL3 regulates tumor progression and metastasis in cholangiocarcinoma and serves as a prognostic biomarker. | ||
Cell Cycle TRIM71 binds to IMP1 and is capable of positive and negative regulation of target RNAs. |









